Priority Research Area Infections

Molecular and Experimental Mycobacteriology

Mission   Projects   Funding   Techniques   Publications    Staff



  • German Center for Infection Research (DZIF) - Tuberculosis Translational Unit (TTU TB): Coordination site, infrastructure: Laboratory for Next Generation Sequencing (EpiMyc)
  • TBseqDISK: molecular test based on Next Generation Sequencing for rapid diagnosis and comprehensive resistance determination in tuberculosis
  • TB Sequel: Comorbidities, risk factors and longterm sequelae defining the individual outcome and public health impact of TB disease



  • SeqMDRTB_NET: Network for application of sequencing technology for the fight against resistant tuberculosis in high incidence settings
  • PHIMS-TB: German wide integrated molecular surveillance of TB



  • Trans Evo: PhD programme for translational evolutionary research



  • MDR-TBNet: Hostpathogen interactions in MultidrugResistant Tuberculosis (MDRTB): Study of the Molecular Epidemiology, Host Immune Responses and GenomeBased Prediction and Early Identification of MDRTB in High Tuberculosis Burden Settings


HORIZON 2020/European Developing Countries Clinical Trials Partnership (EDCTP)

  • WANETAM: West Africa Network of Excellence for TB, AIDS and Malaria
  • RaPaed-AIDA-TB: Rapid and Accurate Diagnosis of Paediatric TB - An AIDA (Assessment of Innovative Diagnostics and Algorithms for Early and Sensitive Detection of Acute TB) platform study


European Centre for Disease Prevention and Control (ECDC)

  • EUseqMyTB: Pilot study on the use of Whole Genome Sequencing for molecular typing and characterization of tuberculosis in the EU/EEA


Innovative Medicines Initiative (IMI)

  •  ETBRA: European tuberculosis regimen accelerator: Characterization of new compounds active against TB


European Union

  • CORVOS: Complement Regulation and Variations in opportunistic infections: Definition of the role of complement for TB infection with respect to strain variation
  • DRTB-HDT: Stratified host-directed therapy for drug resistant tuberculosis: a randomized controlled multi-centre trial


Wellcome Trust/ Bill&Melinda Gates Foundation

  • Cryptic/Wellcome Trust: Comprehensive Resistance Prediction for Tuberculosis: An International Consortium


Leibniz ScienceCampus

  • EvoLUNG: Evolutionary Medicine of the Lung


Leibniz Center Infection

  • Epigenetic consequences of Mtbc infection: Performance of infection experiments, RNAseq and methylome analysis


European and Developing Countries Clinical Trials Partnership (EDCTP)

  • Core-NB: Collision of three global pandemics: the effect of tuberculosis and HIV on the epidemiological, clinical, virological and immunological trajectory of COVID-19 in Botswana and Namibia

Core-NB is an observational study supported by EDCTP and conducted by epidemiologists and researchers from Namibia, Botswana and Germany...
more informations